Plx3397: Clinical Trials

1 trial of Plx3397, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Plx3397: new trials by email Literature Review of Plx3397 trials Research Report on Plx3397

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
Pexidartinib - Tenosynovial Giant Cell Tumor
Phase 4CompletedDaiichi Sankyo322020-10-202024-12-30

Conditions studied

Giant Cell Tumor of Tendon Sheath (1)

Sponsors

Daiichi Sankyo (1)

Countries

Australia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United States (1)